Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.
- Climbing The Blockchain Ladder To Optimize Clinical Supply Forecasting
- Counting The Steps To Decentralized Personalized Therapy Manufacturing
- 3 Strategies For mAb Manufacturing: How Do You Choose?
- Trends In FDA FY 2024 Inspection-Based Warning Letters
- Challenges In Manufacturing TIL For Clinical Trials
- 4 Key Steps To Build Supply Chains For Later-Stage Clinical Trials In LMICs
- The Rise Of AI-Powered Drones In Clinical Logistics And Supply Chains
- Deciphering FDA's 7-Step Framework For AI-Driven Decision-Making
ON-DEMAND WEBINARS
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.
Gain insight into how a patient-centric approach to supply chain innovation in early phase development can accelerate your advanced therapy clinical trial programs.
This webinar demystifies the term “agile,” from an operational perspective, while highlighting the speed and flexibility these systems offer to be able to support complex protocols that require accelerated changes.
This panel webinar discusses the importance of clinical supply agility and how to mitigate supply chain risk that comes along with clinical supply decisions.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Vials pharma manufacturing GettyImages-618518692]( "Planning Your Packaging For A Seamless Transition From Clinic To Launch")
Planning Your Packaging For A Seamless Transition From Clinic To LaunchExplore how clinical and commercial teams should work together for clinical supply packaging, how the COVID-19 pandemic has changed things, and what to consider when looking for a packaging partner.
-
![Sperm-bank-GettyImages-1333952315]( "Cryobag Container Development For Cell & Gene Therapies")
Cryobag Container Development For Cell & Gene TherapiesISR Reports addresses the logistical challenges faced by developers of cell and gene therapies regarding cold chain and cryopreservation.
-
![Pharma Manufacturing GettyImages-1135140594]( "Outsourcing Your Highly Potent Oncology Drug Product")
Outsourcing Your Highly Potent Oncology Drug ProductPrecision oncology treatments require specialized manufacturing and packaging, leading companies to outsource production. Assessing a CDMO’s highly potent processing capabilities is critical.
-
![GettyImages-1404941712-Capsules_Blister_Packaging]( "Gain Confidence In Clinical Trial Outcomes")
Gain Confidence In Clinical Trial OutcomesDelve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
![Internet-Medical-Things-iStock-914789708]( "How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment Numbers")
How Are You Labeling Your IP? Protect Your Clinical Trial With Distinct Treatment NumbersExplore why engaging randomization and trial supply management (RTSM) services early in study startup can help protect clinical trials and expose substantial efficiencies, effectively baking in practices that help streamline supply chains.
-
![Machine Converyor With Glass Vials GettyImages-498492002]( "Building Robust Clinical Supply Chains To Support Global Trials")
Building Robust Clinical Supply Chains To Support Global TrialsEnsuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.
-
![GettyImages-944060504 coworkers computer]( "Top 5 Dos And Don'ts Of RTSM")
Top 5 Dos And Don'ts Of RTSMDiscover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
![GettyImages-980809416 clinical supply]( "Consolidating Clinical Supply Chain Operations With GxP Inventory")
Consolidating Clinical Supply Chain Operations With GxP InventoryA Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.
-
![Refrigerated Container cold chain]( "Transportation Solutions For Cell And Gene Therapy Supply Chains")
Transportation Solutions For Cell And Gene Therapy Supply ChainsDeveloping a strong supply chain for your cell and gene therapy can make your company a more attractive target for acquisition as well as a more competitive player in the commercial environment.
-
![iStock-1213895723-cold chain-packaging-logistics-storage]( "Overcoming Cell Therapy Supply Chain Challenges")
Overcoming Cell Therapy Supply Chain ChallengesFor the industry to realize the potential of cell and gene therapies (CGTs), we must develop improved solutions that reliably support the control and transport of critical CGT raw materials and products.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
